CG Oncology, Inc.

CGON chart

CG Oncology, Inc. news

• Guggenheim maintains CG Oncology at Buy, lowers price target to $89 from $90

  TradingView · Nov 9, 10:40 AM EST

• CG Oncology (CGON) Following Q3 Earnings Has A Stronger Case For Its Valuation

  Simply Wall St · Nov 7, 12:21 PM EST

• H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100

  Moomoo · Nov 6, 5:32 PM EST

• CG Oncology, Inc. (CGON) Misses Q3 EPS by 4c

  StreetInsider · Nov 6, 4:28 PM EST

• Is a 19.77% CG Oncology (NASDAQ:CGON) Rally Already Pricing In Its Bladder Trial?

  kalkine.ca · Nov 6, 1:02 PM EST

• Why is CG Oncology stock surging today?

  Investing.com · Nov 6, 12:28 PM EST

• CG Oncology Stock After Earnings Losses Widen and Revenue Slips

  Simply Wall St · Nov 6, 11:21 AM EST

• Form 8K CG Oncology Inc For: 6 November By Investing.com

  Investing.com Nigeria · Nov 6, 11:12 AM EST

• Wedbush Adjusts Price Target on CG Oncology to $84 From $80, Keeps Outperform Rating

  www.marketscreener.com · Nov 6, 10:06 AM EST

• CG Oncology Q3FY26 Results: Net loss widens to $56.9M, R&D up 41%

  scanx.trade · Nov 6, 9:35 AM EST

• Earnings Flash (CGON) CG Oncology Posts Q3 Net Loss $0.64 a Share, vs. FactSet Est of $0.84 Loss

  www.marketscreener.com · Nov 6, 9:12 AM EST

• CG Oncology, Inc. (CGON) Reports Q3 Loss, Beats Revenue Estimates

  Yahoo Finance · Nov 6, 8:55 AM EST

CG Oncology, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 10-Q10-Q2026-11-06
• 8-K8-K2026-11-06
• 10-Q10-Q2026-08-06
• 8-K8-K2026-08-06
• 8-K8-K2026-06-08
• 8-K8-K2026-05-26
• 10-Q10-Q2026-05-08
• 8-K8-K2026-05-08
• DEF 14ADEF 14A2026-04-24
• 8-K8-K2026-04-13
• 10-K10-K2026-02-27
• 8-K8-K2026-02-27

About CG Oncology, Inc.

Ticker

CGON (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Dallas, TX

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1991792

Frequently asked questions